To Be An Uncited Scientist Is No Cause For Shame

When a play opens on Broadway, it's sure to be reviewed in the New York Times and other major papers, while off-Broadway productions may open and close without getting even a single mention in the press. Similarly, most papers brought to readers of such prestigious publications as the New England Journal of Medicine, Science, and Nature will be "reviewed"--that is, cited--in the science press, while thousands published in lower-impact journals may not be quoted even after 10 years. The extent

Written byEugene Garfield
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

The extent of a paper's "citedness," then, is fairly predictable. If it's published in a high-impact journal, it is highly likely to be cited. If it's published in a lower-impact periodical, it may remain uncited--even if it received high marks in prepublication peer review or is frequently read.

But the discussion of "uncitedness" shouldn't stop there. It is among the least understood yet most discussed issues among people who have little direct knowledge of the research process--and it is an issue that tends to have considerable impact on scientists' views of themselves and the work they do. Millions of papers have remained uncited in the history of scholarship but, to my knowledge, there has never been a thorough study of the reasons for uncitedness or why it should cause doubt about a scientist's talent among those responsible for approving or rejecting applications for research funding.

Perhaps the largest population of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies